Work

Short‐Duration Pan‐Genotypic Therapy With Glecaprevir/Pibrentasvir for 6 Weeks Among People With Recent Hepatitis C Viral Infection

Year: 2019

Type: article

Study design: Clinical Trial

Source: Hepatology

DOI: 10.1002/hep.31003

Authors: Marianne Martinello, Chloe Orkin, Graham Cooke, Sanjay Bhagani, Edward Gane, Ranjababu Kulasegaram, David Shaw, Elise Tu, Kathy Petoumenos, Philippa Marks, Jason Grebely, Gregory J. Dore, Mark Nelson, Gail V. Matthews

Institutions: Blacktown & Mount Druitt Hospital, UNSW Sydney, St Vincent's Hospital Sydney, Kirby Institute, Queen Mary University of London, St Mary's Hospital, The Royal Free Hospital, Auckland City Hospital, Guy's Hospital, St Thomas' Hospital, Royal Adelaide Hospital, Chelsea and Westminster Hospital

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Australian Government, National Institute for Health and Care Research, University of New South Wales

Awards: Accelerating the Elimination of Hepatitis C in the UK, G1689325646, G93685128

OpenAlex ID: W2981389908

FWCI: 1.625

Cites: 28

Cited by: 43

Related to: 10